These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation. Lan T, Kisseleva T, Brenner DA. PLoS One; 2015 Dec; 10(7):e0129743. PubMed ID: 26222337 [Abstract] [Full Text] [Related]
3. Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo. Jiang JX, Chen X, Serizawa N, Szyndralewiez C, Page P, Schröder K, Brandes RP, Devaraj S, Török NJ. Free Radic Biol Med; 2012 Jul 15; 53(2):289-96. PubMed ID: 22618020 [Abstract] [Full Text] [Related]
4. The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91(phox) mediate hepatic fibrosis in mice. Paik YH, Iwaisako K, Seki E, Inokuchi S, Schnabl B, Osterreicher CH, Kisseleva T, Brenner DA. Hepatology; 2011 May 15; 53(5):1730-41. PubMed ID: 21384410 [Abstract] [Full Text] [Related]
6. Alsin and SOD1(G93A) proteins regulate endosomal reactive oxygen species production by glial cells and proinflammatory pathways responsible for neurotoxicity. Li Q, Spencer NY, Pantazis NJ, Engelhardt JF. J Biol Chem; 2011 Nov 18; 286(46):40151-62. PubMed ID: 21937428 [Abstract] [Full Text] [Related]
7. Targeting NADPH oxidase with a novel dual Nox1/Nox4 inhibitor attenuates renal pathology in type 1 diabetes. Gorin Y, Cavaglieri RC, Khazim K, Lee DY, Bruno F, Thakur S, Fanti P, Szyndralewiez C, Barnes JL, Block K, Abboud HE. Am J Physiol Renal Physiol; 2015 Jun 01; 308(11):F1276-87. PubMed ID: 25656366 [Abstract] [Full Text] [Related]
8. Upregulation of cannabinoid receptor-1 and fibrotic activation of mouse hepatic stellate cells during Schistosoma J. infection: role of NADPH oxidase. Wang M, Abais JM, Meng N, Zhang Y, Ritter JK, Li PL, Tang WX. Free Radic Biol Med; 2014 Jun 01; 71():109-120. PubMed ID: 24657416 [Abstract] [Full Text] [Related]
13. NADPH Oxidase 1 Mediates Acute Blood Pressure Response to Angiotensin II by Contributing to Calcium Influx in Vascular Smooth Muscle Cells. Park JM, Do VQ, Seo YS, Kim HJ, Nam JH, Yin MZ, Kim HJ, Kim SJ, Griendling KK, Lee MY. Arterioscler Thromb Vasc Biol; 2022 May 01; 42(5):e117-e130. PubMed ID: 35354309 [Abstract] [Full Text] [Related]
14. Reduced nicotinamide adenine dinucleotide phosphate oxidase 2 plays a key role in stellate cell activation and liver fibrogenesis in vivo. Jiang JX, Venugopal S, Serizawa N, Chen X, Scott F, Li Y, Adamson R, Devaraj S, Shah V, Gershwin ME, Friedman SL, Török NJ. Gastroenterology; 2010 Oct 01; 139(4):1375-84. PubMed ID: 20685364 [Abstract] [Full Text] [Related]
15. APX-115, a first-in-class pan-NADPH oxidase (Nox) inhibitor, protects db/db mice from renal injury. Cha JJ, Min HS, Kim KT, Kim JE, Ghee JY, Kim HW, Lee JE, Han JY, Lee G, Ha HJ, Bae YS, Lee SR, Moon SH, Lee SC, Kim G, Kang YS, Cha DR. Lab Invest; 2017 Apr 01; 97(4):419-431. PubMed ID: 28165467 [Abstract] [Full Text] [Related]
16. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) and liver fibrosis: A review. Mortezaee K. Cell Biochem Funct; 2018 Aug 01; 36(6):292-302. PubMed ID: 30028028 [Abstract] [Full Text] [Related]
17. Role of NADPH oxidases in liver fibrosis. Paik YH, Kim J, Aoyama T, De Minicis S, Bataller R, Brenner DA. Antioxid Redox Signal; 2014 Jun 10; 20(17):2854-72. PubMed ID: 24040957 [Abstract] [Full Text] [Related]
18. Combined NOX1/4 inhibition with GKT137831 in mice provides dose-dependent reno- and atheroprotection even in established micro- and macrovascular disease. Gray SP, Jha JC, Kennedy K, van Bommel E, Chew P, Szyndralewiez C, Touyz RM, Schmidt HHHW, Cooper ME, Jandeleit-Dahm KAM. Diabetologia; 2017 May 10; 60(5):927-937. PubMed ID: 28160092 [Abstract] [Full Text] [Related]
19. Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy. Jha JC, Gray SP, Barit D, Okabe J, El-Osta A, Namikoshi T, Thallas-Bonke V, Wingler K, Szyndralewiez C, Heitz F, Touyz RM, Cooper ME, Schmidt HH, Jandeleit-Dahm KA. J Am Soc Nephrol; 2014 Jun 10; 25(6):1237-54. PubMed ID: 24511132 [Abstract] [Full Text] [Related]
20. Inhibition of NOX1/4 with GKT137831: a potential novel treatment to attenuate neuroglial cell inflammation in the retina. Deliyanti D, Wilkinson-Berka JL. J Neuroinflammation; 2015 Jul 30; 12():136. PubMed ID: 26219952 [Abstract] [Full Text] [Related] Page: [Next] [New Search]